| abstract |
Topical preparations, e.g. creams, ointments, foams, pastes or gels, contain the anti-inflammatorily active glucocorticoid 2-chloro-6 alpha ,9 alpha -difluoro-16 alpha -methyl-11 beta , 17 alpha ,21-trihydroxy-pregna-1,4-diene-3,20-dione (2- chloroflumethasone, halometasone) and the antimicrobial agent 2,4,4'-trichloro-2'-hydroxy-diphenyl ether (triclosan). The preparations are used for the treatment of infected forms of acute eczematous dermatoses and strongly inflamed dermatomycoses or pyodermias. |